awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33685876-219C666B-1FAD-4795-9F99-3B8C74A2C3F5
Q33685876-219C666B-1FAD-4795-9F99-3B8C74A2C3F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33685876-219C666B-1FAD-4795-9F99-3B8C74A2C3F5
Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
P2860
Q33685876-219C666B-1FAD-4795-9F99-3B8C74A2C3F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33685876-219C666B-1FAD-4795-9F99-3B8C74A2C3F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23f4193f802f5dfde9c6c82a5f5592c3674e2664
P2860
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocar